Skip to content

Investor Relations / Publications / Other Publications Referenced in Amarin’s Investor Communications

Other Publications Referenced in Amarin’s Investor Communications

To search publications using the available search words, please click here:

Wong ND, Toth PP, Amsterdam EA, on behalf of the American Society for Preventive Cardiology, Most Important Advances in Preventive Cardiology During this Past Decade: Viewpoint from the American Society for Preventive Cardiology, Trends in Cardiovascular Medicine (2019),doi: https://doi.org/10.1016/j.tcm.2019.11.013

Budoff M, Brent Muhlestein J, Le VT, May HT, Roy S, Nelson JR. Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study. Clin Cardiol. 2018;1–7.
Free:

https://doi.org/10.1002/clc.22856
copyright
© 2021, Amarin Corporation
Privacy policy  |  Disclaimer
Dublin Office
Spaces South Docklands
Block C
77 Sir John Rogerson's Quay
Dublin 2, D02 VK60
Investor Relations
AMARIN CORPORATION PLC C/O AMARIN PHARMA, INC.
440 ROUTE 22
BRIDGEWATER, NJ 08807
investor.relations@amarincorp.com
Fax:
+1 908 719 3012

Amarin Corporation